The trial enrolled patients who received a triplet chemotherapy regimen of nab-paclitaxel, cisplatin, and gemcitabine.

A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic ...

A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...

Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II ...

Researchers found that treating precancerous pancreatic lesions with experimental KRAS inhibitors slowed tumor development ...

Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II clinical trial (RCT), offering an early signal that could reshape how advanced ...

A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors. Using an experimental therapy to target microscopic ...

Two sisters have issued a warning after losing both of their healthy parents to a 'silent killer' form of cancer ...

For the first time in 30 years, there is a new FDA-approved treatment for locally advanced pancreatic cancer.

Propanc Biopharma, Inc. (Nasdaq: PPCB) is developing a novel approach to preventing cancer recurrence and metastasis by targeting and eradicating cancer stem cells through proenzyme activation. The ...